Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.9, 2013-09, pp. : 1273-1285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer

By Chen Chi-qi Chen Cheng-shui Chen Jun-jie Zhou Lian-ping Xu Hong-lei Jin Wei-wei Wu Jian-bo Gao Shen-meng

Molecular and Cellular Biochemistry, Vol. 383, Iss. 1-2, 2013-11 ,pp. : 137-148

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Markers of Various Stages of Non-Small-Cell Lung Cancer

By Zborovskaya I. B. Tatosyan A. G.

Molecular Biology, Vol. 38, Iss. 2, 2004-03 ,pp. : 155-164

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Methylation Profile of Several Tumor Suppressor Genes in Non-Small-Cell Lung Cancer

By Zemlyakova V. V. Zhevlova A. I. Zborovskaya I. B. Strelnikov V. V. Laktionov K. K. Zaletaev D. V. Nemtsova M. V.

Molecular Biology, Vol. 37, Iss. 6, 2003-11 ,pp. : 836-840

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer

By Mozzoni Paola Banda Iris Goldoni Matteo Corradi Massimo Tiseo Marcello Acampa Olga Balestra Valeria Ampollini Luca Casalini Angelo Carbognani Paolo Mutti Antonio

Biomarkers, Vol. 18, Iss. 8, 2013-12 ,pp. : 679-686

Informa Healthcare

Access to resources Recommend Favorite

miR‐134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non‐small cell lung cancer cells

FEBS Open Bio, Vol. 586, Iss. 20, 2012-10 ,pp. : 3761-3765

John Wiley & Sons Inc

Access to resources Recommend Favorite